Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.
2.

Secretory breast carcinoma in a man diagnosed by fine needle aspiration biopsy. A case report.

Pohar-Marinsek Z, Golouh R.

Acta Cytol. 1994 May-Jun;38(3):446-50.

PMID:
8191840
3.

Recurrent secretory carcinoma in residual mammary tissue after mastectomy.

Mies C.

Am J Surg Pathol. 1993 Jul;17(7):715-21.

PMID:
8391221
4.

Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical, ultrastructural, and flow-cytometric study.

Alós L, Cardesa A, Bombí JA, Mallofré C, Cuchi A, Traserra J.

Semin Diagn Pathol. 1996 May;13(2):138-47.

PMID:
8734420
6.

Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.

Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J.

Anticancer Res. 2002 Jan-Feb;22(1A):295-8.

PMID:
12017306
7.
8.

Role of immunocytochemistry and DNA flow cytometry in the fine-needle aspiration diagnosis of malignant small round-cell tumors.

Brahmi U, Rajwanshi A, Joshi K, Ganguly NK, Vohra H, Gupta SK, Dey P.

Diagn Cytopathol. 2001 Apr;24(4):233-9.

PMID:
11285617
9.
10.

Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis.

Amin MB, de Peralta-Venturina MN, Ro JY, El-Naggar A, Mackay B, Ordonez N, Mani A, Ayala A.

Am J Surg Pathol. 1999 Dec;23(12):1455-63. Review.

PMID:
10584698
11.

Epithelial-myoepithelial carcinoma of the salivary glands: a clinico-pathologic, immunohistochemical and DNA flow cytometric study of three cases.

Tralongo V, Rodolico V, Nagar C, Mancuso A, Salvato M, Daniele E.

Anticancer Res. 1997 Jan-Feb;17(1B):761-8.

PMID:
9066617
12.

Secretory carcinoma coexistent with mucinous carcinoma in the breast. Report of a case.

Tamura G, Mikawa S, Monma N.

Acta Pathol Jpn. 1989 Sep;39(9):593-8.

PMID:
2556885
13.

Florid papillomatosis of the nipple: immunohistochemical and flow cytometric analysis of two cases.

Myers JL, Mazur MT, Urist MM, Peiper SC.

Mod Pathol. 1990 May;3(3):288-93.

PMID:
2163532
14.

Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters.

Dodd LG, Kerns BJ, Dodge RK, Layfield LJ.

J Surg Oncol. 1997 Apr;64(4):280-7; discussion 287-8.

PMID:
9142183
15.

Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.

Tanioka F, Hiroi M, Yamane T, Hara H.

Zentralbl Pathol. 1993 Aug;139(3):185-93.

PMID:
8105885
17.

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

Poller DN, Snead DR, Roberts EC, Galea M, Bell JA, Gilmour A, Elston CW, Blamey RW, Ellis IO.

Br J Cancer. 1993 Jul;68(1):156-61.

18.

Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.

Tanoguchi K, Sasano H, Yabuki N, Kikuchi A, Ito K, Sato S, Yajima A.

Mod Pathol. 1998 Feb;11(2):186-93.

PMID:
9504690
19.
20.

Flow cytometric S-phase fraction measurement in breast carcinoma: Influence of software and histogram resolution.

Jourdan ML, Ferrero-Poüs M, Spyratos F, Romain S, Martin PM, Chassevent A.

Cytometry. 2002 Jun 1;48(2):66-70.

Items per page

Supplemental Content

Write to the Help Desk